|
[1]El-SERAG HB, RUDOLPH KL.Hepatocellular carcinoma:edemiology and molecular carcinogenesis[J].Gastroenterology, 2007, 132 (7) , 2557-2576.
|
|
[2]World Health Organization Mortality Database.WHO statistical information system[S/OL].2008[2013-08-20].http://www.who.int/whosis/en/.
|
|
[3]KASSAHUN WT, FANGMANN J, HARMS J, et al.Liver resection and transplantation in the management of hepatocellular carcinoma:a review[J].Exp Clin Transplant, 2006, 4 (2) :549-558.
|
|
[4]CHO WC.Conquering cancer through discovery research[J].IUBMB Life, 2010, 62 (9) :655-659.
|
|
[5]CHO WC.Molecular diagnostics for monitoring and predicting therapeutic effect in cancer[J].Expert Rex Mol Diagn, 2011, 11 (1) :9-12.
|
|
[6]SEGAL E, KIM SK.The modular era of functional genomics[J].Genome Biol, 2003, 4 (5) :317.
|
|
[7]KIM YS, MARUVADA P.Frontiers in metabolomics for cancer research:Proceedings of a National Cancer Institute workshop[J].Metabolomics, 2008, 4 (2) :105-113.
|
|
[8]NICHOLSON JK, LINDON JC, HOLMES E.Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J].Xenobiotica, 1999, 29 (11) :1181-1189.
|
|
[9]NICHOLSON JK, LINDON JC.Systems biology:Metabonomics[J].Nature, 2008, 455 (7216) :1054-1056.
|
|
[10]NICHOLSON JK, CONNELLY J, LINDON JC, et al.Metabonomics:a platform for studying drug toxicity and gene function[J].Nat Rev Drug Discov, 2002, 1 (2) :153-161.
|
|
[11]TAILOR J, KING RD, AHMANN T.Application of metabolomics to plant genotype discrimination using statistics and machine learning[J].Bioinformatics, 2002, 18 (Suppl 2) :241-248.
|
|
[12]ZHU W, LI M, JIN MC.Clinical features of primary hepatic carcinoma:an analysis of 90 cases[J].J Clin Hepatol, 2013, 29 (6) :499-461. (in Chinese) 朱伟, 李明, 金满春.90例原发性肝癌临床特点分析[J].临床肝胆病杂志, 2013, 29 (6) :449-466.
|
|
[13]HENRY CM.New'ome'in town[J].Chem Eng New, 2002, 804 (8) :66-67.
|
|
[14]NG DJY, PASIKANTI KK, CHANECY.Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites[J].Metabolomics, 2011, 7 (2) :155-178.
|
|
[15]XIAO ZH, LI J.Application of metabolomics in study on hepatocellular carcinoma[J].Chin J Biologicals, 2012, 25 (7) :929-931. (in Chinese) 肖忠华, 李晶.代谢组学在肝细胞癌研究中的应用[J].中国生物制品学杂志, 2012, 25 (7) :929-931.
|
|
[16]ZHAO H, LIAO J, LIU Y, et al.alpha-fetoprotein and primary hepatic carcinoma[J].J Clin Hepatol, 2008, 24 (5) :385-387. (in Chinese) 赵恒, 廖静, 刘瑜, 等.甲胎蛋白与肝癌[J].临床肝胆病杂志, 2008, 24 (5) :385-387.
|
|
[17]GU JR.Primary liver cancer:challenges and perspectives[M].London:Springer London, Limited, 2012:160.
|
|
[18]LI ZF, WANG J, CHEN H, et al.Gas chromatography/time-offlight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis:elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis[J].Rapid Commun Mass Spectrom, 2010, 24 (18) :2765-2775.
|
|
[19]TAN YX, YIN PY, TANG L.Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients:potential biomarkers effective for small hepatocellular carcinoma diagnosis[J].Mol Cell Proteomics, 2012, 11 (2) :m111.
|
|
[20]CHEN F, XUE J, ZHOU L, et al.Identification of serum biomarkers of hepatocarcinoma through liquid chromato-graphy/mass spectrometry-based metabonomic method[J].Anal Bioanal Chem, 2011, 401 (6) :1899-1904.
|
|
[21]CHEN TL, XIE GX, WANG XY.Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma[J].Mol Cell Proteomics, 2011, 10 (7) :m110.
|
|
[22]ZHOU LN, WANG QC, YIN PY, et al.Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases[J].Anal Bioanal Chem, 2012, 403 (1) :203-213.
|
|
[23]GAO H, LU Q, LIU X, et al.Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis[J].Cancer Sci, 2009, 100 (4) :782-785.
|
|
[24]WU H, XUE R, DONG L, et al.Metabolic profiling of human urine in hepatocellular carcinoma patients using gaschromatography/mass spectrometry[J].Anal Chim Acta, 2009, 648 (1) :98-104.
|
|
[25]YANG J, XU G, ZHENG Y, et al.Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 813 (1-2) :59-65.
|
|
[26]YANG Y, LI C, NIE X, et al.Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning1H NMR spectroscopy in conjunction with multivariate data analysis[J].J Proteome Res, 2007, 6 (7) :2605-2614.
|
|
[27]HUANG Q, TAN Y, YIN P, et al.Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics[J].Cancer Res, 2013, 73 (16) :4992-5002.
|
|
[28]ZHOU HG, CHEN HB, YU XY, et al.Application of metabolomics in early diagnosis of malignant tumors[J].Jilin Univ:Med Edit, 2013, 39 (1) :184-187. (in Chinese) 周红光, 陈海彬, 俞晓忆, 等.代谢组学在恶性肿瘤早期诊断中的应用[J].吉林大学学报:医学版, 2013, 39 (1) :184-187.
|
DownLoad: